Zobrazeno 1 - 10
of 340
pro vyhledávání: '"Venken T."'
Autor:
More S; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Bonnereau J; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Wouters D; Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.; KU Leuven Institute for Single Cell Omics (LISCO), University of Leuven, KU Leuven, Leuven, Belgium.; KU Leuven Institute for Artificial Intelligence (Leuven.AI), University of Leuven, KU Leuven, Leuven, Belgium., Spotbeen X; KU Leuven Institute for Single Cell Omics (LISCO), University of Leuven, KU Leuven, Leuven, Belgium.; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Karras P; Laboratory for Molecular Cancer Biology, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Oncology, KU Leuven, 3000 Leuven, Belgium., Rizzollo F; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Killian T; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.; Laboratory of Neurophysiology in Neurodegenerative Disorders, VIB-KU Leuven, Leuven, Belgium., Venken T; Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.; Translational Genetics Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Naulaerts S; Laboratory of Cell Stress & Immunity, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium., Vervoort E; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Ganne M; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Nittner D; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.; Spatial Multiomics Expertise Center, VIB-KU Leuven Center for Cancer Biology, 3000 Leuven, Belgium., Verhoeven J; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Bechter O; LKI, Department of General Medical Oncology, Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Bosisio F; Department of Pathology, UZ Leuven, Leuven, Belgium., Lambrechts D; Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.; Translational Genetics Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Sifrim A; Department of Human Genetics, University of Leuven, KU Leuven, Leuven, Belgium.; KU Leuven Institute for Single Cell Omics (LISCO), University of Leuven, KU Leuven, Leuven, Belgium.; KU Leuven Institute for Artificial Intelligence (Leuven.AI), University of Leuven, KU Leuven, Leuven, Belgium., Stockwell BR; Department of Biological Sciences and Department of Chemistry, Columbia University, New York, NY 10027, USA., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Marine JC; Laboratory for Molecular Cancer Biology, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Oncology, KU Leuven, 3000 Leuven, Belgium., Agostinis P; Cell Death Research and Therapy Laboratory, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Publikováno v:
Science advances [Sci Adv] 2024 Oct 18; Vol. 10 (42), pp. eadp6164. Date of Electronic Publication: 2024 Oct 16.
Autor:
Loverix L., Vergote I., Busschaert P., Vanderstichele A., Venken T., Boeckx B., Harter P., Brems H., Van Nieuwenhuysen E., Pignata S., Baert T., Gonzalez-Martin A., Han S., Marth C., Neven P., Colombo N., Berteloot P., Mäenpää J., Olbrecht S., Laga T., Sablon E., Ray-Coquard I., Pujade-Lauraine E., Lambrechts D., Van Gorp T.
Publikováno v:
European Journal of Cancer. 188:131-139
Background: The PAOLA-1/ENGOT-ov25 trial showed improved progression-free (PFS) and overall survival (OS) in homologous recombination deficient (HRD) positive patients treated with olaparib, but not when HRD negative (HRD tested with MyChoice CDx PLU
Autor:
Venken T; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Miller IS; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Arijs I; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Thomas V; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Barat A; Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Betge J; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Zhan T; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Gaiser T; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Ebert MP; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany., O'Farrell AC; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Prehn J; Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Klinger R; UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland., O'Connor DP; Department of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Moulton B; Cancer Trials Ireland, Dublin, Ireland., Murphy V; Cancer Trials Ireland, Dublin, Ireland., Serna G; Val d'Hebron Institute of Oncology, Barcelona, Spain., Nuciforo PG; Val d'Hebron Institute of Oncology, Barcelona, Spain., McDermott R; Cancer Trials Ireland, Dublin, Ireland.; Department of Medical Oncology, Tallaght University Hospital, Dublin, Ireland.; Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland., Bird B; Bon Secours Cork Cancer Centre, Bon Secours Hospital Cork, Cork, Ireland., Leonard G; University Hospital Galway, Newcastle Road, Galway, Ireland., Grogan L; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland., Horgan A; Department of Medical Oncology, South East Cancer Center, University Hospital Waterford, Waterford, Ireland., Schulte N; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Moehler M; Department of Medicine, Johannes-Gutenberg University Clinic, Mainz, Germany., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. diether.lambrechts@kuleuven.be.; VIB Center for Cancer Biology, Leuven, Belgium. diether.lambrechts@kuleuven.be., Byrne AT; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. annettebyrne@rcsi.ie.
Publikováno v:
NPJ genomic medicine [NPJ Genom Med] 2024 May 29; Vol. 9 (1), pp. 33. Date of Electronic Publication: 2024 May 29.
Autor:
Naulaerts, S, Datsi, A, Borras, DM, Antoranz Martinez, A, Messiaen, J, Vanmeerbeek, I, Sprooten, J, Laureano, RS, Govaerts, J, Panovska, D, Derweduwe, M, Sabel, MC, Rapp, M, Ni, W, Mackay, S, Van Herck, Y, Gelens, L, Venken, T, More, S, Bechter, O, Bergers, G, Liston, A, De Vleeschouwer, S, Van Den Eynde, BJ, Lambrechts, D, Verfaillie, M, Bosisio, F, Tejpar, S, Borst, J, Sorg, RV, De Smet, F, Garg, AD
Publikováno v:
Science Translational Medicine. 15
Clinically relevant immunological biomarkers that discriminate between diverse hypofunctional states of tumor-associated CD8 + T cells remain disputed. Using multiomics analysis of CD8 + T cell features across multiple patient cohorts and tumor types
Autor:
Heylen E; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Verstraete P; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Van Aerschot L; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Geeraerts SL; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Venken T; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Timcheva K; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Nittner D; Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Verbeeck J; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Royaert J; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute (LKI), Leuven, Belgium., Gijbels M; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht, The Netherlands.; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands., Uyttebroeck A; Leuven Cancer Institute (LKI), Leuven, Belgium.; Paediatric Haematology and Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, Paediatric Oncology, KU Leuven, Leuven, Belgium., Segers H; Leuven Cancer Institute (LKI), Leuven, Belgium.; Paediatric Haematology and Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, Paediatric Oncology, KU Leuven, Leuven, Belgium., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Cools J; Leuven Cancer Institute (LKI), Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Molecular Biology of Leukemia, Department of Human Genetics, KU Leuven, Leuven, Belgium., De Keersmaecker K; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium. kim.dekeersmaecker@kuleuven.be.; Leuven Cancer Institute (LKI), Leuven, Belgium. kim.dekeersmaecker@kuleuven.be., Kampen KR; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium. k.kampen@maastrichtuniversity.nl.; Leuven Cancer Institute (LKI), Leuven, Belgium. k.kampen@maastrichtuniversity.nl.; Maastricht University Medical Centre, Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht, The Netherlands. k.kampen@maastrichtuniversity.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 May; Vol. 128 (10), pp. 1862-1878. Date of Electronic Publication: 2023 Mar 17.
Autor:
Cappuyns, S., Venken, T., Stoffels, S., Philips, G., Laleman, W., van der Merwe, S., van Malenstein, H., Lambrechts, D., Dekervel, J.
Publikováno v:
In Annals of Oncology June 2022 33 Supplement 4:S241-S241
Autor:
Vanderstichele A; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Busschaert P; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Landolfo C; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK., Olbrecht S; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Coosemans A; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Immunovar Research Group, KU Leuven, Leuven, Belgium., Froyman W; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Loverix L; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Concin N; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria., Braicu EI; Department of Gynecology, Campus Virchow, Charité, Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Wimberger P; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany., Van Nieuwenhuysen E; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium., Han SN; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium., Van Gorp T; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium., Venken T; VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Heremans R; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Neven P; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium., Bourne T; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Van Calster B; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Timmerman D; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Lambrechts D; VIB Center for Cancer Biology, Leuven, Belgium. diether.lambrechts@kuleuven.be.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. diether.lambrechts@kuleuven.be., Vergote I; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, KU Leuven, Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.
Publikováno v:
NPJ genomic medicine [NPJ Genom Med] 2022 Apr 28; Vol. 7 (1), pp. 30. Date of Electronic Publication: 2022 Apr 28.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Venken, T.1,2, Alaerts, M.1,2, Souery, D.3, Goossens, D.1,2, Sluijs, S.1,2, Navon, R.4, Van Broeckhoven, C.1,2, Mendlewicz, J.3, Del-Favero, J.1,2 jurgen.delfavero@ua.ac.be, Claes, S.1,5
Publikováno v:
Molecular Psychiatry. Apr2008, Vol. 13 Issue 4, p442-450. 9p. 1 Diagram, 3 Charts, 2 Graphs.
Autor:
Sánchez-Castillo, Anaís1 (AUTHOR), Savelkouls, Kim G.1 (AUTHOR), Baldini, Alessandra1 (AUTHOR), Hounjet, Judith1 (AUTHOR), Sonveaux, Pierre2,3 (AUTHOR), Verstraete, Paulien4 (AUTHOR), De Keersmaecker, Kim4 (AUTHOR), Dewaele, Barbara5 (AUTHOR), Björkblom, Benny6 (AUTHOR), Melin, Beatrice7 (AUTHOR), Wu, Wendy Y.7 (AUTHOR), Sjöberg, Rickard L.8 (AUTHOR), Rouschop, Kasper M. A.1 (AUTHOR), Broen, Martijn P. G.9 (AUTHOR), Vooijs, Marc1 (AUTHOR), Kampen, Kim R.1,4 (AUTHOR) k.kampen@maastrichtuniversity.nl
Publikováno v:
Oncogenesis. 11/13/2024, Vol. 13 Issue 1, p1-18. 18p.